The effect of diabetes and the common diabetogenic TBC1D4 p.Arg684Ter variant on cardiovascular risk in Inuit in Greenland
Abstract Cardiovascular disease (CVD) is a well-known complication of diabetes, but the association has not been studied among Inuit in Greenland. The aim was to examine the association between diabetes and incident CVD among Inuit in Greenland and determine if the common diabetogenic TBC1D4 variant...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b7078b340f8c4ce48c137ac95eaee21d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:b7078b340f8c4ce48c137ac95eaee21d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b7078b340f8c4ce48c137ac95eaee21d2021-12-02T11:57:56ZThe effect of diabetes and the common diabetogenic TBC1D4 p.Arg684Ter variant on cardiovascular risk in Inuit in Greenland10.1038/s41598-020-79132-12045-2322https://doaj.org/article/b7078b340f8c4ce48c137ac95eaee21d2020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-79132-1https://doaj.org/toc/2045-2322Abstract Cardiovascular disease (CVD) is a well-known complication of diabetes, but the association has not been studied among Inuit in Greenland. The aim was to examine the association between diabetes and incident CVD among Inuit in Greenland and determine if the common diabetogenic TBC1D4 variant confers increased risk of CVD. We followed an initial study population of 4127 adults in Greenland who had participated in at least one population-based health survey, in national registers. We used Poisson regression to calculate incidence rate ratios (IRR) of cardiovascular endpoints, comparing participants with and without diabetes and comparing homozygous TBC1D4 carriers with heterozygous carriers and non-carriers combined. Close to 10% had diabetes and age range was 18–96 years (45% male). Of the 3924 participants without prior CVD, 362 (~ 9%) had CVD events during a median follow-up of 10 years. Multivariate IRR for the effect of diabetes on CVD was 1.12 (95% CI: 0.80, 1.57) p = 0.50. Using a recessive genetic model, we compared homozygous TBC1D4 carriers with wildtype and heterozygous carriers combined, with a multivariate IRR of 1.20 (95% CI: 0.69, 2.11) p = 0.52. Neither diabetes nor the TBC1D4 variant significantly increased CVD risk among Inuit in Greenland in adjusted models.Maria OvervadLars Jorge DiazPeter BjerregaardMichael Lynge PedersenChristina Viskum Lytken LarsenNinna SenftleberNiels GrarupTorben HansenMarit Eika JørgensenNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-9 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Maria Overvad Lars Jorge Diaz Peter Bjerregaard Michael Lynge Pedersen Christina Viskum Lytken Larsen Ninna Senftleber Niels Grarup Torben Hansen Marit Eika Jørgensen The effect of diabetes and the common diabetogenic TBC1D4 p.Arg684Ter variant on cardiovascular risk in Inuit in Greenland |
description |
Abstract Cardiovascular disease (CVD) is a well-known complication of diabetes, but the association has not been studied among Inuit in Greenland. The aim was to examine the association between diabetes and incident CVD among Inuit in Greenland and determine if the common diabetogenic TBC1D4 variant confers increased risk of CVD. We followed an initial study population of 4127 adults in Greenland who had participated in at least one population-based health survey, in national registers. We used Poisson regression to calculate incidence rate ratios (IRR) of cardiovascular endpoints, comparing participants with and without diabetes and comparing homozygous TBC1D4 carriers with heterozygous carriers and non-carriers combined. Close to 10% had diabetes and age range was 18–96 years (45% male). Of the 3924 participants without prior CVD, 362 (~ 9%) had CVD events during a median follow-up of 10 years. Multivariate IRR for the effect of diabetes on CVD was 1.12 (95% CI: 0.80, 1.57) p = 0.50. Using a recessive genetic model, we compared homozygous TBC1D4 carriers with wildtype and heterozygous carriers combined, with a multivariate IRR of 1.20 (95% CI: 0.69, 2.11) p = 0.52. Neither diabetes nor the TBC1D4 variant significantly increased CVD risk among Inuit in Greenland in adjusted models. |
format |
article |
author |
Maria Overvad Lars Jorge Diaz Peter Bjerregaard Michael Lynge Pedersen Christina Viskum Lytken Larsen Ninna Senftleber Niels Grarup Torben Hansen Marit Eika Jørgensen |
author_facet |
Maria Overvad Lars Jorge Diaz Peter Bjerregaard Michael Lynge Pedersen Christina Viskum Lytken Larsen Ninna Senftleber Niels Grarup Torben Hansen Marit Eika Jørgensen |
author_sort |
Maria Overvad |
title |
The effect of diabetes and the common diabetogenic TBC1D4 p.Arg684Ter variant on cardiovascular risk in Inuit in Greenland |
title_short |
The effect of diabetes and the common diabetogenic TBC1D4 p.Arg684Ter variant on cardiovascular risk in Inuit in Greenland |
title_full |
The effect of diabetes and the common diabetogenic TBC1D4 p.Arg684Ter variant on cardiovascular risk in Inuit in Greenland |
title_fullStr |
The effect of diabetes and the common diabetogenic TBC1D4 p.Arg684Ter variant on cardiovascular risk in Inuit in Greenland |
title_full_unstemmed |
The effect of diabetes and the common diabetogenic TBC1D4 p.Arg684Ter variant on cardiovascular risk in Inuit in Greenland |
title_sort |
effect of diabetes and the common diabetogenic tbc1d4 p.arg684ter variant on cardiovascular risk in inuit in greenland |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/b7078b340f8c4ce48c137ac95eaee21d |
work_keys_str_mv |
AT mariaovervad theeffectofdiabetesandthecommondiabetogenictbc1d4parg684tervariantoncardiovascularriskininuitingreenland AT larsjorgediaz theeffectofdiabetesandthecommondiabetogenictbc1d4parg684tervariantoncardiovascularriskininuitingreenland AT peterbjerregaard theeffectofdiabetesandthecommondiabetogenictbc1d4parg684tervariantoncardiovascularriskininuitingreenland AT michaellyngepedersen theeffectofdiabetesandthecommondiabetogenictbc1d4parg684tervariantoncardiovascularriskininuitingreenland AT christinaviskumlytkenlarsen theeffectofdiabetesandthecommondiabetogenictbc1d4parg684tervariantoncardiovascularriskininuitingreenland AT ninnasenftleber theeffectofdiabetesandthecommondiabetogenictbc1d4parg684tervariantoncardiovascularriskininuitingreenland AT nielsgrarup theeffectofdiabetesandthecommondiabetogenictbc1d4parg684tervariantoncardiovascularriskininuitingreenland AT torbenhansen theeffectofdiabetesandthecommondiabetogenictbc1d4parg684tervariantoncardiovascularriskininuitingreenland AT mariteikajørgensen theeffectofdiabetesandthecommondiabetogenictbc1d4parg684tervariantoncardiovascularriskininuitingreenland AT mariaovervad effectofdiabetesandthecommondiabetogenictbc1d4parg684tervariantoncardiovascularriskininuitingreenland AT larsjorgediaz effectofdiabetesandthecommondiabetogenictbc1d4parg684tervariantoncardiovascularriskininuitingreenland AT peterbjerregaard effectofdiabetesandthecommondiabetogenictbc1d4parg684tervariantoncardiovascularriskininuitingreenland AT michaellyngepedersen effectofdiabetesandthecommondiabetogenictbc1d4parg684tervariantoncardiovascularriskininuitingreenland AT christinaviskumlytkenlarsen effectofdiabetesandthecommondiabetogenictbc1d4parg684tervariantoncardiovascularriskininuitingreenland AT ninnasenftleber effectofdiabetesandthecommondiabetogenictbc1d4parg684tervariantoncardiovascularriskininuitingreenland AT nielsgrarup effectofdiabetesandthecommondiabetogenictbc1d4parg684tervariantoncardiovascularriskininuitingreenland AT torbenhansen effectofdiabetesandthecommondiabetogenictbc1d4parg684tervariantoncardiovascularriskininuitingreenland AT mariteikajørgensen effectofdiabetesandthecommondiabetogenictbc1d4parg684tervariantoncardiovascularriskininuitingreenland |
_version_ |
1718394829738606592 |